Recent Advances in the Viral Hepatitis C Treatment
Till now few drugs are available for the treatment of hepatitis C disease. But now newer drug category is included which are direct acting antiviral agents. The mechanism of action of direct acting anti-viral drugs is they are the protein molecules that target specific stages in the hepatitis C virus lifecycle and disturbs the viral replication process there by inhibiting the infection. The drugs included under this category include.
Related Conference of Recent Advances in the Viral Hepatitis C Treatment
September 23-24, 2024
15th International Conference on Pulmonary & Respiratory Medicine
Singapore City, Singapore
October 24-25, 2024
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Paris, France
November 28-29, 2024
16th International Conference on Chronic Obstructive Pulmonary Disease
Aix-en-Provence, France
Recent Advances in the Viral Hepatitis C Treatment Conference Speakers
Recommended Sessions
- Advancement in New Drug Discovery for Treatment of Hepatitis
- Critical Care and Hepatology Nursing
- Epidemiology of Hepatitis
- Hepatitis Care
- Hepatocellular Carcinoma
- Intestinal Rehabilitation
- Liver Cancer
- Liver Diseases Diagnosis
- Liver Fibrosis
- Liver Transplantation and Surgery
- Molecular Biology of Hepatitis A, B, C, D and E Viruses
- Pancreatic Diseases
- Pathophysiology of Hepatitis
- Pediatric Gastroenterology, Hepatology and Nutrition
- Pregnancy and Liver Diseases
- Recent Advances in the Viral Hepatitis C Treatment
- Types of Hepatitis
- Viral Hepatitis Management
Related Journals
Are you interested in
- Asthma - Tuberculosis-2024 (France)
- Asthma and Allergy - COPD CONGRESS 2024 (UK)
- Asthma and COPD - COPD_2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - COPD CONGRESS 2024 (UK)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic bronchitis - COPD CONGRESS 2024 (UK)
- Chronic Obstructive Pulmonary Disease - COPD_2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- Co-Morbidities of COPD - COPD_2024 (France)
- COPD and Air Pollution - COPD CONGRESS 2024 (UK)
- COPD and Cardiovascular Diseases - COPD_2024 (France)
- COPD Complications - COPD_2024 (France)
- COPD Exacerbations - COPD_2024 (France)
- COPD Pathogenesis - COPD_2024 (France)
- COPD Pathogenesis - COPD CONGRESS 2024 (UK)
- COPD Therapeutics - COPD_2024 (France)
- COPD-Chronic obstructive pulmonary disease - COPD CONGRESS 2024 (UK)
- COPD: Sign and Symptoms - COPD_2024 (France)
- Depression and Anxiety in COPD - COPD CONGRESS 2024 (UK)
- Depression and anxiety in COPD - COPD_2024 (France)
- Diagnosis and Treatment of COPD - COPD CONGRESS 2024 (UK)
- Drug Discovery of COPD - COPD CONGRESS 2024 (UK)
- Drug Discovery of COPD - COPD_2024 (France)
- Effect of COVID-19 on Lungs - COPD CONGRESS 2024 (UK)
- Emphysema - COPD CONGRESS 2024 (UK)
- Epidemiology of COPD - COPD_2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Genetic risk factor of COPD - COPD_2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung cancer - COPD_2024 (France)
- Lung cancer - COPD CONGRESS 2024 (UK)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - COPD CONGRESS 2024 (UK)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - COPD CONGRESS 2024 (UK)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pathophysiology of COPD - COPD_2024 (France)
- Pediatric Neonatal Care in COPD - COPD CONGRESS 2024 (UK)
- Pediatric Pulmonary, Critical care and Sleep - COPD_2024 (France)
- Pediatric Pulmonology & Critical care - COPD CONGRESS 2024 (UK)
- Prevention of COPD - COPD CONGRESS 2024 (UK)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary diseases - COPD CONGRESS 2024 (UK)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases-treatment and therapies - COPD_2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - COPD_2024 (France)
- Pulmonary Rehabilitation - COPD CONGRESS 2024 (UK)
- Respiratory and sleep Medicine - COPD CONGRESS 2024 (UK)
- Respiratory Failure and COPD Complications: - COPD CONGRESS 2024 (UK)
- Respiratory Tract Infections - COPD CONGRESS 2024 (UK)
- Self-Management and Prevention of COPD - COPD CONGRESS 2024 (UK)
- Self-Management and Prevention of COPD - COPD_2024 (France)
- Spirometry - COPD CONGRESS 2024 (UK)
- Stages & Severity on Lung Diseases - COPD CONGRESS 2024 (UK)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tobacco control - COPD CONGRESS 2024 (UK)
- Types of COPD - COPD_2024 (France)
- Types of COPD - COPD CONGRESS 2024 (UK)
- Zoonotic TB - Tuberculosis-2024 (France)